Benjamin Paluch

Stock Analyst at Roth MKM

(1.35)

# 3,599

Out of 5,090 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$43.30	+50.12%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$10.61	+60.23%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$4.64	+115.52%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $43.30

Upside: +50.12%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $10.61

Upside: +60.23%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $4.64

Upside: +115.52%